<DOC>
	<DOCNO>NCT00911105</DOCNO>
	<brief_summary>Purpose non-interventional study documentation efficacy safety data multiple myeloma therapy combine treatment Lenalidomide Dexamethasone daily routine practice .</brief_summary>
	<brief_title>Non -Interventional Study-Palliative Therapy Multiple Myeloma With Combination Lenalidomide Dexamethasone</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<criteria>Patients multiple myeloma least one previous therapy . 18 year old Signed , write informed consent Pregnancy nurse All exclusion criterion list SmPC ( summary product characteristic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Non-interventional study</keyword>
	<keyword>Lenalidomide</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Observational</keyword>
	<keyword>Time progression</keyword>
	<keyword>Clinical routine</keyword>
	<keyword>Germany</keyword>
	<keyword>Plasmacytoma</keyword>
</DOC>